SCHEMBL22737569

SCHEMBL22737569

c1ccc(-c2nc(-c3ccc(-c4ccc5c(c4)oc4cc(-c6cccc7oc8ccccc8c67)ccc45)cc3)nc(-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.35
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35
PRKDC P78527 2/20 0.34
ALOX5 P09917 1/20 0.34
BACE1 P56817 1/20 0.33
ATM Q13315 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
AHR P35869 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 3/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22737974 0.98 HCRTR1 (0.35) HCRTR1MMP12MMP13PRKDCALOX5
SCHEMBL22737952 0.98 PRKDC (0.35) HCRTR1MMP12MMP13PRKDCALOX5
SCHEMBL22738074 0.98 PRKDC (0.35) HCRTR1MMP12MMP13PRKDCALOX5
SCHEMBL22737567 0.97 PLA2G2A (0.34) HCRTR1MMP12MMP13PRKDCALOX5
SCHEMBL24855980 0.97 HCRTR1 (0.34) HCRTR1MMP12MMP13PRKDCBACE1
SCHEMBL22352160 0.97 HCRTR1 (0.34) HCRTR1MMP12MMP13PRKDCBACE1
SCHEMBL24855976 0.97 HCRTR1 (0.34) HCRTR1MMP12MMP13PRKDCBACE1
SCHEMBL22845223 0.97 HCRTR1 (0.34) HCRTR1MMP12MMP13PRKDCBACE1
SCHEMBL22737810 0.97 HCRTR1 (0.36) HCRTR1MMP12MMP13PRKDCALOX5
SCHEMBL24882763 0.96 HCRTR1 (0.33) HCRTR1MMP12MMP13PRKDCBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459316-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device SAMSUNG SDI CO., LTD. (KR) 2022-10-04 US disclosed
US-20200377489-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377489-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OCIAD1, OCIAD2, OXER1 HCRTR1 196/4885MMP12 2841/4885MMP13 3545/4885
US-11459316-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device OCIAD1, OCIAD2, OXER1 HCRTR1 196/4885MMP12 2841/4885MMP13 3545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.